Dextrose Solution
Product Images NDC 0264-7387

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0264-7387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dextrose Molecular Formula (Dextrose Injection In Titan Container 1)

Chemical structure of Dextrose, showing the molecular arrangement of atoms including hydroxyl groups (OH) and a water molecule (H2O) indicating a hydrated form.*

FDA Label Image

Bag Illustration (Dextrose Injection In Titan Container 2)

An instructional diagram showing a Dextrose intravenous solution bag with labeled features including tear notches and an overwrap around the bag. The diagram highlights the packaging and handling aspects for intravenous administration.*

FDA Label Image

Figure 1 (Dextrose Injection In Titan Container 3)

An instructional diagram showing hands opening the package of an intravenous solution bag. The image illustrates how to peel back the protective cover to access the IV bag containing Dextrose solution 70 g/100 mL by B. Braun Medical Inc.*

FDA Label Image

Bag Hanger Illustration (Dextrose Injection In Titan Container 4)

An instructional diagram showing a hanging intravenous solution bag with labeled components. It highlights the bag hanger at the top, a set port with a green ring, and a blocked port with a red ring at the bottom, indicating connection points for intravenous administration.*

FDA Label Image

Figure 2 (Dextrose Injection In Titan Container 5)

An instructional illustration showing a hand preparing to connect an IV set to a Dextrose solution bag for intravenous administration. Insets demonstrate not cutting the tubing or components improperly, emphasizing correct assembly technique.*

FDA Label Image

Figure 3 (Dextrose Injection In Titan Container 6)

An instructional black and white line drawing showing a pair of gloved hands holding a transparent intravenous solution bag by its top edges. The image focuses on the positioning of the bag, which features two ports at its bottom, likely for fluid administration. This illustration is likely part of a preparation or handling guide for an intravenous solution product.*

FDA Label Image

Recycle Symbol (Dextrose Injection In Titan Container 7)

FDA Label Image

S8705 Container Label (Dextrose Injection In Titan Container 8)

Dextrose Injection USP 70% (70 g/100 mL) pharmacy bulk package solution in a 2000 mL container. Label indicates it is hypertonic, must be diluted before use, and is not for direct infusion. Manufactured by B. Braun Medical Inc. with warnings about compatibility and storage at room temperature (25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.